Valacyclovir HCL 1 gram tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FUCL3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,324
Award facts
- Contract value 100% obligated
- $1,323.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Valacyclovir HCL 1 gram tablets in quantities of 90 units, with a ceiling value of $1,323.54. This is a firm fixed-price delivery order with an ultimate completion date of September 26, 2025, and represents a non-competitive, non-set-aside award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government entities. The company's extensive federal contract portfolio demonstrates its capability to supply a comprehensive range of pharmaceutical products, including both brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The parent IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to fulfill medical supply needs for military healthcare programs worldwide, with the DLA planning to establish Generation V pharmaceutical prime vendor global program contracts with multiple awards across different regions.
Quick answers
Who was awarded contract SPE2DB25FUCL3?
SPE2DB25FUCL3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FUCL3 worth?
The government has obligated $1,324 on SPE2DB25FUCL3.
Is contract SPE2DB25FUCL3 an order under another contract?
Yes. SPE2DB25FUCL3 is a delivery order under SPE2DB22D1041, an indefinite delivery contract.
Was contract SPE2DB25FUCL3 competed?
The extent of competition for SPE2DB25FUCL3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award